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Abstract: Iron deficiency (ID), the leading cause of anemia and the most common nutritional defi-
ciency globally, is not well reported among children in malaria-endemic settings, and little is known
about its contribution to anemia in these settings. We aimed to assess the prevalence of anemia, the
role of ID using multiple parameters, and the factors associated with anemia in a malaria-endemic ru-
ral area. We conducted a community-based cross-sectional study of 432 children aged 1–5 years from
the Popokabaka Health Zone, Democratic Republic of Congo. Sociodemographic characteristics, med-
ical history, anthropometric parameters, and biochemical parameters were considered. Hemoglobin
and malaria prevalence were assessed using rapid finger-prick capillary blood testing in the field.
Venous blood samples were analyzed for serum ferritin, serum iron, total iron-binding capacity, and
C-reactive protein (CRP) in a laboratory. Anemia was found in 294 out of 432 (68%) patients. Malaria
was found in 375 out of 432 (87%), and ID in 1.8% according to diagnosis by adjusted ferritin only
and in 12.9% according to transferrin saturation. ID indicators were not significantly correlated with
low hemoglobin levels. Malaria, fever, and CRP > 5 mg/L were major factors associated with anemia
in Popokabaka. Anemia control should focus on treating inflammatory conditions and infectious
diseases among children in such settings.
Keywords: anemia; iron deficiency; children; malaria; Popokabaka
1. Introduction
Anemia, which is characterized by a hemoglobin level below 11.0 g/dL, continues
to be a serious global public health problem that particularly affects young children and
pregnant women [1]. The World Health Organization (WHO) reported that an estimated
42% of children aged < 5 years are anemic worldwide; the burden is even higher in Africa,
reaching 62.3% [2]. According to the most recent Demographic and Health Survey (DHS)
and the Multiple Indicators Cluster Survey (MICS), the prevalence of anemia among
children aged < 5 years in the Democratic Republic of Congo (DRC) is around 63% [3,4].
While multiple factors are known to cause anemia, the literature [5–8] shows that iron
deficiency (ID), wherein a person has low storage of iron, is the most common nutritional
cause [7–9]. Over several decades, nutritional interventions have been carried out in most
developing countries [7], and nationwide in the DRC [3], to strengthen the prevention of
anemia in childhood. One might have expected a decrease in the incidence of anemia, but
its prevalence remains high. This is particularly evident in malaria-endemic areas [10].
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There is little information to date on ID and its contribution to anemia in the DRC. Large-
scale surveys such as the DHS or MICS have not assessed iron parameters, perhaps
because of the complex logistics and laboratory analysis required. However, some studies
have been conducted, such as the study by Harvey-Leeson et al. in 2016 [11], which
reported a discrepancy in ID prevalence (1% when using adjusted ferritin and 58% with
serum transferrin) among children aged 2–5 years old in the Kongo Central Province,
DRC. The study found that ID anemia (IDA) never exceeded 20%, regardless of the iron
biomarker used. Bahizire et al. [12] conducted a study in the South Kivu Province, DRC,
and reported an ID prevalence of 10.4% (using inflammation-adjusted ferritin), observing
that ID contributed to less than a fifth of anemia cases in children aged < 5 years.
However, according to the WHO [13], half of the anemia cases are expected to be
explained by ID. In this study, we aimed to assess the prevalence of anemia and the role of
ID among children aged < 5 years who presented with anemia, to suggest specific directions
for useful anemia-control strategies. We also assessed possible risk and protective factors
associated with anemia.
2. Materials and Methods
2.1. Study Design and Setting
We conducted a community-based cross-sectional study in the Popokabaka Health
Zone, DRC, between May and June 2019. This region is an entirely rural area located in
Kwango Province, where the population is facing food insecurity and poverty [3]. The
health system is organized around the referral hospital and health centers, coordinated by
the Health Zone management. National strategies regarding malaria and anemia control
are also implemented. For instance, iron and folic acid supplementation to women during
pregnancy and Infant and Young Child Feeding (IYCF) support for children aged up to
2 years are organized at the facility and community levels [3,4]. Malaria-control strategies
are integrated with other disease-control programs under Health Zone management [4].
These include community screening and treatment for mild malaria by community health
workers, the integrated management of severe cases at health facilities, epidemic man-
agement, selective vector control, periodical distribution, and campaigning for the use of
insecticide-treated bed nets. Plasmodium falciparum is the most prevalent malaria-causing
species found in DRC [4]. Available information for the Kwango province shows that
stunting (43%) and wasting (8%) are prevalent in children [4]. The diversity of food is
limited, and the soil is sandy and arid, not permitting the growth of a wide variety of crops.
Farmers preferably grow bitter cassava as a staple food because of its resistance to drought
and the energy value of its roots. Animal food sources, dairy products, and sea products
are seldom consumed.
2.2. Participants and Sampling
A total of 432 children aged 12–59 months were included in this study, based on a
proportional sample size calculation for anemia prevalence = 0.59, a precision d of 0.075, a
design effect of two, and an expected response rate of 0.80. Children were selected using a
three-stage cluster sampling technique. First, we selected five clusters (health areas) among
the nine accessible areas through a probability-proportion-to-size technique. The term
“accessible” considered the time constraints for collecting venous blood samples from the
field and being able to process them within 3 h at the Popokabaka Hospital. Only 9 of the
25 health areas fitted this technical constraint. Second, we randomly selected 3 villages
in each cluster. In the last stage, an equal number of 30 households having children aged
12–59 months old were systematically selected from a detailed list pre-established by
community workers in each village. Only one child from each household was selected and
assessed. A parent had to provide written consent for their child to participate in the study.
Children for whom the parents refused blood drawing or children who were hospitalized
for any diseases in the two previous weeks were excluded.
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2.3. Data Collection and Procedures
Data were collected using a questionnaire completed on tablet computers using the
Survey CTO collect application. The questionnaire consisted of eight modules: household
characteristics; water, hygiene, and sanitation (WASH); household food security (House-
hold Food Insecurity Access Scale-HFIAS); child health history; IYCF; anthropometric
measures; dietary practices (24 h recall and food frequency); and biochemical sampling.
Data collection took two consecutive days in each cluster, three teams working in
parallel for each of the three selected villages of the cluster. A team comprising three data
collectors and two phlebotomists was formed. On the first day, the data collectors visited
the households, obtained consent forms, and completed the surveys for each child selected
in the village. The biological mother or caretaker responded to the questionnaire while
anthropometric measurements were taken for the child. When finished, the personnel
provided a card to the mother with the correct personal identifier for blood collection the
next day. On the second day, the phlebotomists went to the same villages at a specific
identified location (the Health Center or another appropriate place) from 7 to 9 am for
blood collection and hemoglobin and malaria rapid testing. The mothers were then invited
to bring the children and the cards for blood collection.
The data collectors were trained by the investigator on the survey questionnaire and
interview techniques, and the phlebotomists were trained by a lab expert on appropriate
standard operating procedures (SOPs) and blood sample management.
2.4. Blood Processing and Management
The phlebotomist first performed a capillary finger-prick test for hemoglobin (Hgb)
assessment (Hemocue 301) and a rapid test for malaria in the field. The information
was recorded using tablet computers and the Survey CTO application. Additionally, the
phlebotomist collected up to 6 mL of venous blood from the child using trace-element-free
serum BD vacutainers (BD-368380) and powder-free sterile disposable gloves. Tourniquet
application took a maximum of one minute. The collected blood was allowed to clot for at
least 30 min in the field at room temperature and was then transported to the Popokabaka
Hospital within 3 h. There, it was centrifuged, and the supernatant was separated at
2300 rpm for 10 min using a Hettich Rotor 32A centrifuge (Tuttlingen, Germany). The
serum was aliquoted into two polypropylene vials: 0.5 mL tricoded FluidX, Brooks Life
Science vials and 2 mL Sarstedt vials.
All the vials were immediately stored in a −40 ◦C freezer that worked nonstop on
solar energy during the day and on a generator overnight in Popokabaka. When the survey
was complete, the samples were transported from Popokabaka to Kinshasa (a 12 h vehicle
trip with self-transported fuel) stored in liquid nitrogen. Then, every sample was stored at
−80 ◦C in an ultra-low freezer at the Kinshasa School of Public Health for a week before
being shipped on dry ice to Norway.
All the 0.5 mL vials were sent to Haukeland University Hospital (Bergen, Norway) for
the analysis of serum ferritin (using electrochemiluminescence immunoassay (ECLIA)),
C-reactive protein (S-CRP) (using the immunoturbimetry method), and total iron-binding
capacity (S-TIBC, using the Berekna equation calculation: s-TIBC = s-Transferrin * 25.1).
Two-milliliter vials were sent to the Norwegian University of Life Sciences (Ås, Norway)
for the analysis of serum iron and other minerals (using the Agilent 8900 Triple Quadrupole
inductively coupled plasma mass spectrometer (ICP-MS)).
Transferrin saturation (TSAT), expressed as a percentage, was then calculated as the
value of serum iron divided by the TIBC.
2.5. Transformation of Variables
Anthropometric indices including the weight for height, height for age, weight for
age, and mid-upper-arm circumference for age and their Z-scores were calculated using the
WHO Anthro software. Wasting was defined as a weight-for-height Z-score (WHZ) < −2,
stunting was defined as a height-for-age Z-score < −2, and underweight was defined as
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a weight-for-age Z-score < −2. Wealth index quintiles were generated using principal
component analysis on ownership variables in the household. The food consumption score
was calculated using data from the Food Frequency Questionnaire (FFQ) and categorized
as adequate, borderline, and inadequate consumption. The dietary diversity variable was
generated from 24 h food recall, capturing the intake of common food items in the area. The
Household Food Insecurity Access Score (HFIAS) and its categories were also calculated.
2.6. Anemia and ID Definition
Anemia was defined as Hgb levels < 11 g/dL [14]. According to the level, it was
classified as mild, moderate, or severe when the Hgb concentrations were 10–10.9, 7.0–9.9,
or <7.0 g/dL, respectively. ID was defined as serum ferritin concentrations < 12 µg/L in
the absence of inflammation [14]. To account for inflammation [8], we used the regression-
correction approach developed by the Biomarkers Reflecting Inflammation and Nutritional
Determinants of Anemia (BRINDA) [15] to estimate the prevalence of ID. The regression-
correction approach followed a three-step process. First, we defined internal reference
values for inflammatory markers (CRPref) as the tenth percentile [15]. Then, we estimated
the regression coefficient (β) for the association between CRP and ferritin using univariable
linear regression models, with ferritin as the dependent variable. Finally, we calculated
CRP-adjusted ferritin values using the following equation:
Adjusted ferritin = unadjusted ferritin − β (CRPobs − CRPref).
We also estimated ID by calculating TSAT by dividing the serum iron (Fe3+) levels by
the TIBC. A child is said to have ID when TSAT is <20% [14].
A child was said to have malaria when there was a positive result in the rapid malaria
test for Plasmodium falciparum.
2.7. Statistical Analysis
All the data were merged and analyzed using STATA 14.0. We performed a descrip-
tive analysis. The median and 25th–75th percentiles are reported for continuous variables
that were not normally distributed, while the mean (SD) is used for continuous variables
that were normally distributed. Frequencies are used to describe categorical data. The
confidence intervals (CIs) for prevalence were calculated using a normal Z-test. Moreover,
an independent-sample t-test or the Wilcoxon rank-sum test were used to compare, respec-
tively, mean or median values. A Pearson chi-squared test was used to test for association,
with anemia as the outcome. The Spearman correlation coefficients were used to describe
the relationships between the iron biomarkers and hemoglobin concentrations. Linear
regression was used to adjust ferritin for inflammation (CRP). Bivariable and multiple
logistic regression were used to identify factors associated with anemia, and the crude and
adjusted odds ratios (ORs) were reported. The regression model was constructed by a
forward stepwise selection approach with covariate inclusion probability (p-value of crude
OR) < 0.20. Multicollinearity was checked for all the covariates included in the regression
model. All the statistical analyses were performed at the 0.05 level of confidence.
3. Results
3.1. Characteristics of the Study Population
In total, 432 children aged 1–5 years old were included in this study. The general
characteristics of the enrolled children are shown in Table A1. The boy/girl ratio was
1:1, and their median (P25–P75) age was 32 (22–43) months. Children aged 48–59 months
were underrepresented compared to those in the other age groups. Fever onset during the
2 weeks preceding the study visits was common among the children in Popokabaka and
more so among anemic children (63.3%) than those without anemia (45.7%) (Table A2).
The results also support the existence of childhood health and anemia-control strategies
implemented in Popokabaka, but not with optimal coverage (Table A2). Almost seven
out of ten children had benefitted from deworming in the previous 6 months, while half
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had received vitamin A in the previous six months. About one third (35.6%) were treated
with iron supplements or syrups, suggesting that nutritional therapy for anemia was
also practiced.
Stunting was the most common form of malnutrition, with more than half of the
children (56%) affected, and every tenth (11%) child exhibited wasting. Only one in three
had a diversified diet, and approximately 3% of the children were defined as being obese.
3.2. Prevalence and Distribution of Anemia and Iron Deficiency
The prevalence of malaria in Popokabaka was 86.8% (95% CI, 83.6–90.0%) according to
Plasmodium falciparum rapid testing. We found that anemia was also common, at 68.1% (95%
CI, 64.0–72.0%), with severe anemia seen among 3.3% (95% CI, 1.9–5.4%) of the children.
Half of the children (49.4%) had signs of inflammation, with CRP > 5 mg/L. This
proportion was significantly higher among anemic children than nonanemic children
(53.5% vs. 40.7%, p value = 0.001).
However, ID was less prevalent when taking all the iron biomarkers into account.
First, considering that ferritin increases in the acute phase of inflammation, we deter-
mined the unadjusted ferritin prevalence by excluding the ferritin values of children with
CRP > 5 mg/L during calculation. Only one out of 193 children presented with ID (fer-
ritin < 12 µg/L). In another approach, accounting for inflammation as proposed by the
BRINDA project [15], we found an ID prevalence of 1.8% (95% CI, 0.5–3.0%) using the
ferritin biomarker adjusted for CRP. The latter approach, where the adjustment was per-
formed using linear regression, allowed the inclusion of all the observations where we had
measured serum CRP and ferritin concentrations. This prevalence was lower than those
based on other indicators. Table A3 shows that the ID prevalence according to the TSAT
biomarker was the highest, at 12.9% (95% CI, 9.6–16.1%).
We estimated the IDA prevalence and the contribution of ID to anemia, and the former
7.5% according to transferrin saturation and 1.5% according to adjusted ferritin. Thus, the
remaining anemia cases were not iron-deficiency-related.
3.3. Correlation with Iron Biomarkers
Hgb was not correlated with transferrin saturation (TSAT) but showed a weak, nega-
tive correlation with ferritin (r = −0.17) and serum iron (r = 0.07) (Table A4). In addition,
Hgb was negatively correlated with CRP, suggesting a possible role of inflammatory
conditions or diseases in anemia genesis.
3.4. Association with Anemia
Table A5 shows the multivariable regression analysis with determinants for anemia
among children aged under five years in Popokabaka. We found that malaria (OR, 4.08
(2.18–9.68)), fever during the previous two weeks (OR, 1.71 (1.08–2.70)), and signs of
inflammation (CRP > 5 mg/L) (OR, 1.65 (1.05–2.59)) were associated with anemia. However,
ID according to TSAT was inversely associated with anemia (OR, 0.50 (0.27–0.97)), meaning
that the presence of ID did not imply or protect against anemia for the data collected.
4. Discussion
In the present study, we demonstrated the burden of ID and anemia using multiple
biomarkers for a representative community-based sample of children in a poor part of the
DRC, which, to the best of our knowledge, had not been assessed before. Our study found
that anemia was highly prevalent (68.1%) among children aged < 5 years, while ID was
remarkably low (12.9% according to TSAT, 7.9% according to TIBC, and 1.8% according
to regression-adjusted ferritin biomarkers). This anemia prevalence seemed much higher
than the previously reported national prevalence (59.9%, n = 8280) according to the latest
Demographic and Health Survey in 2014 [3]. This may indicate that children in Popokabaka
are at the highest risk of anemia complications in the DR Congo. Harvey-Leeson et al. [11]
reported an anemia prevalence rate of 44% in Kongo Central Province, while Bahizire [12]
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reported a prevalence of 46.6% in rural Kivu, both of which are areas known for long
periods of civil unrest. This difference could be explained by the fact that our study was
specifically carried out in a small geographical area, a “health zone”, where the problem
is indeed serious. In this case, the prevalence may be higher than that in a much larger
research area. Another reason of this difference is that we did not adjust the Hgb levels for
altitude and ethnicity, and this may have increased the false-negative proportion in our
anemia classification. In other words, a reduction in this prevalence could be expected if
those factors were also considered.
The WHO reports that almost 50% of anemia could be caused by ID and argues that
ID is the “single” largest contributor to the anemia burden [16]. However, this was not
the case in our study population. We found a very low prevalence of ID, with the highest
prevalence being 12.9% according to TSAT. This is consistent with the findings of Harvey-
Leeson [11], in the western part of the DRC (Kongo Central Province), and Bahazire [12],
in the eastern part of the DRC (Kivu Province). Gebreegziabher et al. [17] reported the
same situation in rural southern Ethiopia among women of reproductive age. By contrast,
Muriuki et al. investigated iron prevalence across five countries in Africa [18] and found
a much higher pooled prevalence of ID, 34.3%. The difference might be due to the high
prevalence of malaria and inflammation in our population. In fact, under these conditions,
the prevalence of ID according to ferritin could be underestimated because of the bias
of ferritin toward higher concentrations. Another reason might be the systematic iron
supplementation strategy for children with anemia in Popokabaka, causing iron repletion.
Motadi et al. [19] also found a much higher prevalence according to TSAT (12%) than
adjusted ferritin (2.3%). Moreover, Muriuki et al. [18] reported that TSAT is the most
sensitive and specific marker compared to the gold standard, which is regression with
adjusted ferritin in African children. Dignass et al. [20] also suggested the use of TSAT
rather than ferritin in the context of chronic inflammatory diseases. In a review published
in 2020, Capellini et al. [21] emphasized that, in the context of inflammation, the TSAT
biomarker is more sensitive and less biased than a ferritin cutoff of 100 µg/L.
The high anemia prevalence with very low iron storage depletion in this highly
prevalent malaria context cannot be explained in the present study. However, we anticipate,
based on the existing literature [22,23], that in the malaria-endemic context, hemoglobin
genetic disorders (e.g., the sickle cell trait) and high iron supplementation may be common
explanations. The biological pathway involves an increase in iron absorption capacity in
some of these conditions even though the storage capacity is normal. Taking into account
the low consumption of animal-source foods in Popokabaka, a possible explanation is a
frequent consumption of iron-rich vegetables (e.g., cassava and amaranth) [24] and the
widespread self-prescription of iron tablets [12].
Another explanation could be possible iron supplementation (syrups or tablets) ad-
ministered at home to anemic children by parents in Popokabaka, even though only
35% of those who took part in our study reported that their children had received iron
supplementation in the previous three months (Table A1).
In a recent review, Camaschella et al. [25] explained the endocrine regulatory role
of hepcidin in iron balance. According to their review, proinflammatory cytokines such
as interleukin-6 increase hepcidin levels during acute and chronic inflammation, which
leads to iron-restricted erythropoiesis and anemia of inflammation. According to this
pathway, we would have expected a high prevalence of iron deficiency in children living
in a malaria-endemic setting. However, this was not the case in our study. We found a
low prevalence of ID in the children of Popokabaka. Camaschella et al. discussed another
pathway through which unexpectedly elevated levels of serum iron might be induced
along with anemia, especially in individuals with iron-loading anemias or chronic anemia:
low levels of, the inhibition of, or the loss of control of hepcidin. We did not assess hepatic
hepcidin in our study but suspect that this protein would be low and probably impacted by
recurrent protein malnutrition (in our study, we found that one in ten children had acute
malnutrition while one in two was chronically malnourished) or other hepcidin disorders.
Nutrients 2021, 13, 1010 7 of 13
We estimated the association between anemia and other factors in a multivariate logis-
tic regression analysis, and we found that fever in the previous two weeks, malaria status,
and inflammation status (CRP > 5 mg/L) were factors associated with anemia. Taking into
account the weak correlation of hemoglobin with iron biomarkers, we hypothesized from
these results that the remaining cases of anemia could be explained or have been caused by
malaria or other diseases that we did not explore in our study. Unfortunately, we did not as-
sess other illnesses such as helminthic infections [26,27]. Chaparro and Suchdev [28], when
framing causal models for anemia determinants, emphasized malaria, poor sanitation,
underweight, inflammation, stunting and vitamin A deficiency.
We used rapid malaria tests to determine the prevalence of parasitemia based only on
the presence of Plasmodium falciparum. This could have underestimated the true prevalence
of malaria in terms of parasite count. In a review of how malaria was associated with
anemia, White [10] stated that, in endemic malaria contexts, young children had repeated
symptomatic infections, with high rates of asymptomatic parasitemia, and often had
chronic anemia.
In our study, anemia prevalence was indifferently distributed within nutritional
parameters—food insecurity, dietary diversity, and anthropometric indicators—which did
not explain any of the variation in anemia. This finding is in contrast to the summary
findings reported by the WHO [7], indicating that multiple nutrient deficiencies of both
minerals and vitamins are causes of anemia.
The present study had several strengths. This was a community-based biochemical
study for a hard-to-reach rural settlement with many sample-conservation constraints.
We obtained a representative study population from Popokabaka through a probabilistic
sampling scheme with a large sample size. We demonstrated that iron deficiency might
not be the main cause of anemia in such malaria-endemic areas, that malaria itself or other
inflammatory conditions may be leading factors. We examined multivariate regression
models and checked for multicollinearity to validate the associated factors found.
However, the study had several limitations. The study population was restricted to
technically accessible areas in the study area, as explained in Section 2.2, to avoid damage to
proteins and possible hemolysis due to long distances from the field to the referral hospital.
Future research in such hard-to-reach areas could consider on-site blood processing and
serum conservation for a higher representation of distant areas. We acknowledge that the
analysis of more biomarkers would have had scientific value, such as soluble transferrin
receptors and hepcidin. We conducted a cross-sectional study, so we cannot argue any
causality for the relationships reported in this study. We think that the protective effect of
iron deficiency on anemia was related to the medium sample size, to such an extent that
this would become null with a bigger sample.
Despite the fact that the interpretation of Hgb concentrations requires some adjust-
ments (for altitude and ethnicity) as recommended by the literature [29,30], for this study,
we did not consider any adjustments for altitude or ethnicity. The reasons were that we
did not capture geo coordinates (altitude) during data collection and that the Popokabaka
Health Zone is a small, relatively flat and low-altitude region inhabited by the same Yaka
population. In these conditions, the misclassification of anemia would have been minor
and would not have affected our findings.
Finally, anemia has complex pathways, and there are likely to be other important
factors involved that were not measured.
5. Conclusions
Iron deficiency should be considered prevalent in populations when its prevalence is
more than 20%. In this study, we demonstrated a low iron deficiency prevalence within a
context of high anemia and malaria prevalence in Popokabaka. ID was not a risk factor for
anemia in this study. However, malaria was a major contributor to anemia. Further research
with more hematological biomarkers is needed to characterize this anemia, which was
not explained by ID. Due to the findings from this study, we suggest that anemia control
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strategies in Popokababa focus on malaria prevention and other childhood infectious-
disease controls for effective impact.
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Appendix A
Table A1. General characteristics and anthropometry of children aged 1–5 years in Popokabaka.
Total
Anemia p-Value
Report Unit Yes No
Age (months)




12–23 124 (28.7) 86 (29.3) 38 (27.5)
24–35 120 (27.8) 81 (27.5) 39 (28.3)
36–47 116 (26.8) 78 (26.5) 38 (27.5)
48–59 72 (16.7) 49 (16.7) 23 (16.7)
Gender n (%)
0.927Boys 224 (51.8) 152 (51.7) 72 (52.2)
Girls 208 (48.2) 142 (48.3) 66 (47.8)
Height-for-Age Z-score
Mean (SD) −2.2 (1.7) −2.2 (1.7) −2.0 (1.7) 0.255
Weight-for-Height
Z-score Mean (SD) −0.6 (1.3) −0.7 (1.2) −0.3 (1.4) 0.011
Weight-for-Age Z-score
Mean (SD) −1.5 (1.4) −1.7 (1.3) −1.3 (1.3) 0.014




Report Unit Yes No
Stunting n (%)
0.632Yes 242 (56.0) 167 (56.8) 75 (54.4)
No 190 (44.0) 127 (43.2) 63 (45.6)
Wasting n (%)
0.913Yes 48 (11.1) 33 (11.2) 15(10.9)
No 384 (88.9) 261 (88.8) 123 (89.1)
Underweight n
(%)
0.103Yes 152 (35.2) 111 (37.8) 41 (29.7)
No 280 (64.8) 183 (62.2) 97 (70.3)
Diversified diet in last 24
h n (%)
0.432Yes 133 (39.8) 87 (29.6) 46 (33.3)
No 299 (69.2) 207 (70.4) 92 (66.7)




Diarrhea in last 2 weeks
n (%)
0.187Yes 78 (18.1) 58 (19.7) 20 (14.5)
No 354 (81.9) 236 (80.3) 118 (85.5)
Bloody stools in last 2
weeks
0.801Yes 18 (4.17) 13 (4.4) 5 (3.6)
No 414 (95.8) 281 (95.6) 133 (96.4)
Fever in last 2 weeks
0.001Yes 249 (57.6) 186 (63.3) 63 (45.7)
No 183 (42.4) 108 (36.7) 75 (54.4)
Cough in last 2 weeks
0.819Yes 141 (32.64) 97 (33.0) 44 (31.9)
No 291 (67.4) 197 (67.0) 94 (68.1)
Zinc tablets in last 2 weeks 0.649
Yes 23 (5.3) 17 (5.8) 6 (4.4)
No 409 (94.7) 277 (94.2) 132 (95.6)
Vitamin A supplements in
last 6 months 0.520
Yes 232 (53.7) 161 (54.7) 71 (51.5)
No 200 (46.3) 133 (45.2) 67 (48.5)
Deworming in last 6
months
0.865Yes 306 (70.8) 209 (71.1) 97 (70.3)
No 126 (29.2) 85 (28.9) 41 (29.7)





Iron supplements in last 3
months
0.077Yes 154 (35.6) 113 (38.4) 41 (29.7)
No 278 (64.4) 181 (61.6) 97 (70.3)
Sleeping under mosquito
nets 0.406
Yes 260 (60.2) 173 (58.8) 87 (63.0)
No 172 (39.8) 121 (41.2) 51 (37.0)
Table A3. Prevalence and distribution of anemia, iron deficiency, and malaria.
n % (95% CI )
Anemia
Anemia, all types (Hgb < 11.0 g/dL) 294/432 68.1 (64.0–72.0)
Severe anemia (Hgb < 7.0 g/dL) 14/432 3.3 (1.9–5.4)
Moderate anemia (Hgb 7.0–9.9 g/dL) 153/432 35.4 (31.0–40.1)
Mild anemia (Hgb 10.0–10.9 g/dL) 127/432 29.4 (25.3–33.9)
Iron Deficiency
ID as unadjusted ferritin < 12 µg/L when
CRP < 5 1/193 0.5 (0.5–1.5)
ID as CRP-adjusted ferritin < 12 µg/L 7/400 1.8 (0.5–3.0)
ID as TIBC > 66 umol/L 33/419 7.9 (5.2–10.5)
ID as TSAT < 20% 55/412 12.9 (9.6–16.1)
Malaria and Inflammation
Malaria (positive rapid P. falciparum test) 375/432 86.8 (83.6–90.0)
CRP < 5 mg/L 207/419 49.4 (44.6–54.0)
Table A4. Spearman correlation of hemoglobin with iron biomarkers, r coefficient (p-value).
Hemoglobin Ferritin CRP TSAT SerumIron TIBC
Hemoglobin 1.000
Ferritin −0.17 (0.002) 1.000
CRP −0.19 (0.000) 0.35 (0.000) 1.000
TSAT −0.02 (0.765) 0.31 (0.000) −0.08 (0.161) 1.000
Serum
Iron 0.07 (0.170) 0.07 (0.170) −0.18 (0.000) 0.83 (0.000) 1.000
TIBC 0.14 (0.011) −0.51 (0.000) −0.19 (0.000) −0.46 (0.000) 0.04 (0.502) 1.000
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Table A5. Factors associated with anemia, crude and adjusted odds ratios (ORs) reported.
Bivariate Estimates Multivariate Logistic RegressionAnalysis
OR Crude CI p Value OR Adjusted CI p Value
Age 0.99 0.97–1.01 0.505 - - -
Household size 1.05 0.96–1.13 0.277 - - -
Sex
Girl 1.01 0.68–1.52 0.927 - - -
Boy 1
Diarrhea in last 2 weeks
Yes 1.45 0.83–2.52 0.187 1.26 0.63–2.52 0.519
No 1
Bloody stools in last 2 weeks
Yes 1.23 0.43–3.52 0.699 - - -
No 1
Fever in last 2 weeks
Yes 2.05 1.36–3.09 0.001 1.71 1.08–2.70 0.020
No 1
Deworming in last 6 months
Yes 1.03 0.66–1.61 0.865 - - -
No 1
Iron supplementation last 3
months








Yes 0.83 0.55–1.27 0.406 - - -
No 1
Stunting
Yes 1.10 0.74–1.65 0.632 - - -
No 1
Wasting
Yes 1.04 0.54–1.97 0.913 - - -
No 1
Underweight
Yes 1.43 0.93–2.21 0.103 1.37 0.73–2.54 0.321
No 1
Dietary diversity
Yes 0.84 0.54–1.30 0.432 - - -
No 1
CRP
>5 mg/L 1.68 1.10–2.54 0.015 1.65 1.05–2.59 0.029
≤5 mg/L 1
ID by TSAT
Yes 0.62 0.34–1.12 0.116 0.50 0.27–0.97 0.038
No 1
Malaria
Yes 5.02 2.78–9.05 <0.001 4.08 2.18–9.68 <0.001
No 1
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